Related Experiment Video

Updated: Jul 11, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Identification of JAK/STAT signalling components by genome-wide RNA interference

Patrick Müller1, David Kuttenkeuler, Viola Gesellchen

  • 1Department of Molecular Developmental Biology, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany.

Nature
|August 12, 2005
PubMed

Insights

Researchers identified genes crucial for the Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) pathway. This discovery offers new insights into cancer development and potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Cellular signalling pathways are vital for development and homeostasis.
  • Dysregulation of signalling pathways, including the Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) pathway, is linked to human cancers.
  • The JAK/STAT pathway regulates critical cellular processes like proliferation and haematopoiesis.

Purpose of the Study:

  • To conduct a genome-wide survey to identify genes essential for JAK/STAT pathway activity.
  • To classify newly identified interacting proteins based on their functional relationship with known JAK/STAT components.
  • To explore the role of identified genes and their human homologues in cancer biology.

Main Methods:

  • Systematic genome-wide RNA interference (RNAi) screen in Drosophila melanogaster haemocyte-like cells.
  • Analysis of 20,026 RNAi-induced phenotypes to identify interacting genes.
  • Cell-based epistasis experiments to functionally categorize identified proteins.
  • In vivo analysis of specific gene functions in leukaemia models.

Main Results:

  • Identified 90 genes required for JAK/STAT pathway activity, including 4 known and 86 previously uncharacterized proteins.
  • Discovered the tyrosine phosphatase Ptp61F and the Drosophila homologue of BRWD3 (dBRWD3).
  • Demonstrated that disrupted dBRWD3 and overexpressed Ptp61F suppress leukaemia-like blood cell tumours in vivo.

Conclusions:

  • This study provides a comprehensive identification of novel genes involved in JAK/STAT signalling.
  • The findings offer molecular insights into the JAK/STAT pathway's relevance to human cancer.
  • Human homologues of the identified pathway modifiers represent potential therapeutic targets for cancer treatment.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...